Table 10.
NPWTi‐d with reticulated open‐cell foam‐CC not recommended for use: statements and survey results
| Consensus statement | Yes | No | Consensus |
|---|---|---|---|
| ROCF‐CC IS NOT recommended in wounds that contain approximately 100% surface area coverage w/ dry intact eschar | 10/11 (91%) | 1/11 (9%) | Yes |
| ROCF‐CC IS NOT recommended in wounds with presence of exposed, unprotected organs and vessels | 11/11 (100%) | 0/11 (0%) | Yes |
| ROCF‐CC IS NOT recommended in wounds with presence of undrained abscess(es) | 10/11 (91%) | 1/11 (9%) | Yes |
| ROCF‐CC IS NOT recommended in wounds that measure less than 3 × 3 cm in size | 5/11 (45%) | 6/11 (55%) | No |
| ROCF‐CC IS NOT recommended in wounds that measure less than 2 × 2 cm in size. | 8/11 (73%) | 3/11 (27%) | No |
| ROCF‐CC IS NOT recommended in wounds that measure less than 1 × 1 cm in size | 12/12 (100%) | 0/12 (0%) | Yes |
| ROCF‐CC IS NOT recommended over split‐thickness skin grafts | 12/12 (100%) | 0/12 (0%) | Yes |
| ROCF‐CC IS NOT recommended over dermal grafts (eg, autograft, allograft, xenograft, synthetic) | 10/10 (100%) | 0/10 (0%) | Yes |
| ROCF‐CC IS NOT recommended in acutely ischemic wounds | 10/11 (91%) | 1/11 (9%) | Yes |
Abbreviation: NPWTi‐d, negative pressure wound therapy with instillation and dwell time.